PLEASE NOTE: PATIENTS MUST NOT TAKE FOLINIC ACID OR 5-MTHF FOR 48 HOURS PRIOR TO BLOOD DRAW.
Speciment Type: Serum (SST - serum separator collection tube)
Provider acknowledgement: I hereby confirm that the information, including the information related to medical necessity as provided on this form, has been provided to the patient specified below and/or their legal guardian about the test(s) to be performed, and the patient specified below and/or their legal guardian has given consent for the test(s) to be performed. I confirm that the person listed as the ordering provider who has signed below is authorized by law to order the test(s) requested herein.
Cost of FRAT® testing is $295 (please select preferred payment method PRIOR to testing)
PATIENT CONSENT & AUTHORIZATIONS
Patient acknowledgment: My healthcare provider has provided me with information regarding the tests requested on this form. I agree that I am voluntarily submitting this sample for analysis. I authorize my provider to release the sample and any other necessary records as requested to Religen Inc. and for Religen Inc. to release the results of FRAT® to the ordering provider. I understand that I am responsible for all charges for FRAT testing.
Religen Inc CLIA ID #: 39D2130307
Reference Lab: Vascular Strategies LLC CLIA ID #: 39D2109943
RI-FMS-0019 version 02; Effective date: 1/1/2025
FRAT® PATENT NO: US7,846,672 B2